This is read by an automated voice. Please report any issues or inconsistencies here. If you’ve injected your weight-loss medication in an airport bathroom, you’re not alone. Or maybe you decided to ...
ATLANTA -- Patients with plateaued weight loss or who reached their weight-related goals on a GLP-1 receptor agonist were able to maintain their improvements in weight, body composition, and metabolic ...
Plenty of evidence shows that GLP-1 medications can help people manage type 2 diabetes and/or obesity. Drugs like Ozempic work by mimicking the hormone that releases insulin from your pancreas, ...
VIENNA — Adults with obesity but without diabetes who took the investigational, oral GLP-1 receptor agonist orforglipron for 72 weeks lost significantly more weight than those on placebo, according to ...
Online health platform Noom recently launched its Noom Microdose GLP-1 Rx Program to reportedly address barriers to GLP-1s, including medication cost. Over the last few years, the popularity of ...
NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (ALUR), a pioneer in metabolically healthy weight loss, today announced initial results on the combination of the Allurion Program with low ...
A small study suggests every-other-week GLP-1 shots could be enough for locking in weight loss — but there are caveats. In a small new study, most people who switched from weekly to every-other-week ...
Still life of Ozempic and Wegovy. Both are injectable prescription weight loss medicines. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) As demand surges for semaglutide ...
SAN DIEGO, CA—Glucagon-like peptide-1 (GLP-1) receptor agonists may be useful for secondary prevention of atrial fibrillation (AF) in patients with obesity and type 2 diabetes, new results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback